Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD3D Score.

Dopheide, Jörn; Ramadani, Hana; Adam, Luise; Gahl, Brigitta; Papac, Lucija; Veit, Jonas; Kaspar, Mathias; Schindewolf, Marc; Baumgartner, Iris; Drexel, Heinz (2020). Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD3D Score. Angiology, 71(7), pp. 658-665. Sage 10.1177/0003319720920155

[img] Text
Dopheide Angiology 2020_epub.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (441kB) | Request a copy
[img]
Preview
Text
Dopheide Angiology 2020_AAM.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).
Under SAGE's Green Open Access policy, the Accepted Version of the article may be posted in the author's institutional repository and reuse is restricted to non-commercial and no derivative uses.

Download (829kB) | Preview
[img]
Preview
Text
Dopheide Angiology 2020_suppl.pdf - Supplemental Material
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (3MB) | Preview

Peripheral artery disease (PAD) is a high-risk condition for cardiovascular (CV) events, but no specific prognosis assessment tool exists. We developed an individual risk score (PAD3D) based on the combined predictive value for mortality, including (1) age, (2) severity of PAD, and (3) extent of atherosclerosis. Patients (n = 1310) with symptomatic PAD were followed up for a mean of 50 ± 26 months. The cohort was randomly subdivided into a test and validation cohort. All-cause and CV mortality were prospectively analyzed for PAD3D score and in combination with classical risk factors. For the test and validation cohort (n = 655 each), all-cause and CV mortality were predicted (P < .001) by the PAD3D score. Additional inclusion of classical risk factors did not increase discrimination compared with PAD3D as "area under receiver-operating characteristic" curves were similar for both scores at any time point. Thus, the addition of the classical risk factors to PAD3D did not further improve the prognostic value. The PAD3D score provides a risk gradient of a 4.5-fold increase in all-cause and CV mortality. We developed a score for precise prediction of all-cause and CV mortality. The PAD3D score promises to allow for personalized goals in risk intervention.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Dopheide, Jörn Fredrik, Adam, Luise Leonore, Gahl, Brigitta, Papac, Lucija, Veit, Jonas, Kaspar, Mathias, Schindewolf, Marc, Baumgartner, Iris

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-3197

Publisher:

Sage

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

08 May 2020 20:04

Last Modified:

20 Feb 2024 14:16

Publisher DOI:

10.1177/0003319720920155

PubMed ID:

32342699

Uncontrolled Keywords:

cardiovascular outcome peripheral artery disease personalized medicine prognostic score risk quantification test and validation cohort

BORIS DOI:

10.7892/boris.143929

URI:

https://boris.unibe.ch/id/eprint/143929

Actions (login required)

Edit item Edit item
Provide Feedback